Narrow search
Showing 1 - 10 of 74
Cover Image
Why is there no AIDS vaccine?
Kremer, Michael (contributor);  … - 2004
Persistent link: https://www.econbiz.de/10003079766
Cover Image
Why are drugs more profitable than vaccines?
Kremer, Michael; Snyder, Christopher M. - 2003
Persistent link: https://www.econbiz.de/10001774942
Cover Image
Preventives Versus Treatments Redux : Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals
Kremer, Michael - 2018
calibration of the global demand for HIV pharmaceuticals, we demonstrate the dramatically sharper analysis achievable with the new …
Persistent link: https://www.econbiz.de/10012930337
Cover Image
Preventives versus treatments redux : tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals
Kremer, Michael; Snyder, Christopher M. - In: Review of industrial organization : RIO 53 (2018) 1, pp. 235-273
Persistent link: https://www.econbiz.de/10012009113
Cover Image
Preventives versus treatments redux : tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals
Kremer, Michael; Snyder, Christopher M. - 2018
Persistent link: https://www.econbiz.de/10011885562
Cover Image
Preventives versus treatments redux : tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals
Kremer, Michael; Snyder, Christopher M. - 2018
Persistent link: https://www.econbiz.de/10011795066
Cover Image
Preventives versus treatments redux : tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals
Kremer, Michael; Snyder, Christopher M. - 2017
Persistent link: https://www.econbiz.de/10011819356
Cover Image
Preventives Versus Treatments Redux : Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals
Kremer, Michael - 2018
calibration of the global demand for HIV pharmaceuticals, we demonstrate the dramatically sharper analysis achievable with the new …
Persistent link: https://www.econbiz.de/10012453507
Cover Image
Optimal subsidies for prevention of infectious disease
Goodkin-Gold, Matthew; Kremer, Michael; Snyder, … - 2020
Persistent link: https://www.econbiz.de/10012390061
Cover Image
Optimal subsidies for prevention of infectious disease
Kremer, Michael; Williams, Heidi; Snyder, Christopher M.; … - 2020
Persistent link: https://www.econbiz.de/10012321099